Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.

Calleja, José Luis

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. [electronic resource] - International journal of colorectal disease Mar 2016 - 543-51 p. digital

Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

1432-1262

10.1007/s00384-015-2461-x doi


Aged
Anemia--blood
Blood Transfusion
Colonic Neoplasms--blood
Erythrocyte Indices
Female
Ferric Compounds--therapeutic use
Hemoglobins--metabolism
Humans
Iron--metabolism
Length of Stay
Male
Maltose--analogs & derivatives
Postoperative Complications--etiology
Transplantation, Homologous
Treatment Outcome